MetLife Inc. (NYSE:MET) has a beta of 1.35, a 12-month trailing P/E ratio of 7.80, and a growth ratio of 2.13. The stock’s Relative Strength Index (RSI) is 60.48, with weekly volatility at 2.02% and ATR at 1.47. The MET stock’s 52-week price range has touched low of $22.85 and a $53.28 high. Its shares traded lower over the last trading session, losing -0.13% on 12/08/20. The shares fell to a low of $47.10 before closing at $47.52. Intraday shares traded counted 7.7 million, which was -32.84% lower than its 30-day average trading volume of 5.80M. MET’s previous close was $47.58 while the outstanding shares total 908.70M.
Investors have identified the Insurance – Life company MetLife Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $42.10 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Potential earnings growth for MetLife Inc. (MET)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the Q3 2020 quarter of the year, MetLife Inc. recorded a total of 16.02 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -16.63% coming in sequential stages and their sales for the Q3 2020 quarter increasing by 11.96%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 15.09 billion trying to sell their products during the last quarter, with the result yielding a gross income of 923.0 million. This allows shareholders to hold on to 908.70M with the recently reported earning now reading 0.70 cents per share. This is a figure that compared to analyst’s prediction for their Q3 2020 (1.73 cents a share).
Having a look at the company’s valuation, the company is expected to record 6.36 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on MET sounds very interesting.
Is the stock of MET attractive?
In related news, Director, Kinney Catherine R sold 3,657 shares of the company’s stock in a transaction that recorded on Aug 13. The sale was performed at an average price of 39.50, for a total value of 144,452. As the sale deal closes, the EVP & Chief Investment Officer, Goulart Steven J now sold 14,200 shares of the company’s stock, valued at 732,649. Also, EVP & Chief Financial Officer, McCallion John D. sold 5,378 shares of the company’s stock in a deal that was recorded on Dec 23. The shares were price at an average price of 51.17 per share, with a total market value of 275,176. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.10%.
10 out of 15 analysts covering the stock have rated it a Buy, while 5 have maintained a Hold recommendation on MetLife Inc.. 0 analysts has assigned a Sell rating on the MET stock. The 12-month mean consensus price target for the company’s shares has been set at $49.55.